Atlas Trials

Phase 2

89,854 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 2

RecordFirmDate
Vibrating, Cold Device for Pediatric Intravenous (IV) Cannulation Pain Relief (NCT01394250)Children's Hospital of Philadelphia2011-06-01
A Multiple Dose Study Of PF-04950615 (RN316) In Subjects On Maximum Doses Of Statins (NCT01350141)Pfizer2011-06-01
Study Evaluating the Safety and Efficacy of MEGF0444A in Combination With Carboplatin, Paclitaxel and Bevacizumab in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Prior Chemotherapy for Advanced Disease (NILE) (NCT01366131)Genentech, Inc.2011-06-01
Topical Interferon Gamma for Macular Edema Secondary to Uveitis (NCT01376362)National Eye Institute (NEI)2011-06-01
PiCCA Study (Panitumumab in Combination With Cisplatin/Gemcitabine) (NCT01320254)Hannover Medical School2011-06-01
Ofatumumab In Older Patients With Untreated Low Or Intermediate Risk Indolent B-Cell Lymphomas (NCT01263418)UNC Lineberger Comprehensive Cancer Center2011-06-01
Efficacy and Tolerability of Riluzole in Treatment Resistant Depression (NCT01204918)Yale University2011-06-01
Linifanib in Treating Patients With Advanced, Refractory Colorectal Cancer (NCT01365910)Vanderbilt-Ingram Cancer Center2011-06-01
A Study of LY2484595 in Japanese Subjects (NCT01375075)Eli Lilly and Company2011-06-01
Treating Kidney Donors With Valganciclovir to Reduce Viral Transmission to Recipients (NCT01329185)University of Minnesota2011-06-01
Military to Civilian: Trial of an Intervention to Promote Postdeployment Reintegration (NCT00640445)Minneapolis Veterans Affairs Medical Center2011-06-01
Clinical Efficacy Trial of Mexiletine for Myotonic Dystrophy Type 1 (NCT01406873)University of Rochester2011-06-01
CHFR Methylation Status Esophageal Cancer Study (NCT01372202)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2011-06-01
Preventing Urinary Tract Infection Post-Surgery (NCT01346774)Betsy Foxman2011-06-01
Evaluation of AL-78898A in Exudative Age-Related Macular Degeneration (NCT01157065)Alcon Research2011-06-01
An Exercise Trial for Acute Myeloid Leukaemia (AML) Patients Undergoing Induction Chemotherapy (NCT01446081)University Health Network, Toronto2011-06-01
Safety and Efficacy Study of TH-302 CNS Penetration in Recurrent High Grade Astrocytoma Following Bevacizumab (NCT01403610)The University of Texas Health Science Center at San Antonio2011-06-01
Safety, Tolerability, Extended Early Bactericidal Activity and PK of Higher Doses Rifampicin in Adults With Pulmonary TB (NCT01392911)Radboud University Medical Center2011-06-01
Erlotinib and Docetaxel in Second Line of Treatment in Patients With Non Small Cell Lung Cancer (NCT01350817)University Hospital, Limoges2011-06-01
Efficacy Study of Combined Treatment With Uric Acid and rtPA in Acute Ischemic Stroke (NCT00860366)Angel Chamorro, MD2011-06-01
Guided Imagery Response in Total Knee Replacement (NCT01491750)Kent State University2011-06-01
Holistic Approaches to Depression (NCT01384916)Butler Hospital2011-06-01
Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma (NCT01290692)TVAX Biomedical2011-06-01
SOX as Adjuvant Chemotherapy for Resectable Gastric Cancer (NCT01542294)Chinese Academy of Medical Sciences2011-06-01
Effect of Probiotic Supplement on Bowel Function (NCT01475929)Danisco2011-06-01
Study of Pegylated Liposomal Doxorubicin and Temsirolimus in Patients With Advanced Hepatocellular Cancer (NCT01281943)Washington University School of Medicine2011-06-01
Lenalidomide for Myelodysplastic Syndrome Refractory to Hypomethylating Agents (NCT01246076)Washington University School of Medicine2011-06-01
Phase I/II Study to Assess the Safety and Activity of Enhanced TCR Transduced Autologous T Cells in Metastatic Melanoma (NCT01350401)Adaptimmune2011-06-01
SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder (NCT01435759)Shire2011-05-31
Airway and/or Pulmonary Vessels Transplantation (NCT01331863)Assistance Publique - Hôpitaux de Paris2011-05-31
BMS-936558 (MDX-1106) In Subjects With Advanced/Metastatic Clear-Cell Renal Cell Carcinoma (RCC) (NCT01354431)Bristol-Myers Squibb2011-05-31
Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast Cancer (NCT01334021)M.D. Anderson Cancer Center2011-05-31
Effect of Aerobic Exercise Training on Cardiorespiratory Function in Patients With Traumatic Brain Injury (NCT01294332)National Institutes of Health Clinical Center (CC)2011-05-26
Glyburide Advantage in Malignant Edema and Stroke Pilot (NCT01268683)Remedy Pharmaceuticals, Inc.2011-05-26
Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf® (NCT01294020)Astellas Pharma Europe Ltd.2011-05-25
A Clinical Research Study to Determine Whether PD 0332991 May Be Effective in Treating Patients With Liver Cancer (NCT01356628)Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University2011-05-25
LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures (NCT01271725)Boehringer Ingelheim2011-05-24
Single-agent Erlotinib in Patients Previously Treated With Oral Etoposide in Protocol OSI-774-205 (NCT01247922)OSI Pharmaceuticals2011-05-23
Phase II PAP Plus GM-CSF Versus GM-CSF Alone for Non-metastatic Prostate Cancer (NCT01341652)University of Wisconsin, Madison2011-05-23
Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer (NCT01266460)Gynecologic Oncology Group2011-05-23
A Study on the Correlation Between Tarceva (Erlotinib) - Induced Rash and Efficacy in EGFR Mutated Participants With Advanced Non-Small Cell Lung Cancer Receiving First-Line Therapy (NCT01174563)Hoffmann-La Roche2011-05-23
Lapatinib in Stage IV Melanoma With ERBB4 Mutations (NCT01264081)National Cancer Institute (NCI)2011-05-20
PercutaneOus StEm Cell Injection Delivery Effects On Neomyogenesis in Dilated CardioMyopathy (The POSEIDON-DCM Study) (NCT01392625)Joshua M Hare2011-05-19
Intrathecal Trastuzumab Administration in Metastatic Breast Cancer Patients Developing Carcinomatous Meningitis (NCT01373710)Institut Curie2011-05-19
Single Agent Armodafinil for Patient-Reported Fatigue Following Radiation Therapy for Head and Neck Cancer (NCT01330446)M.D. Anderson Cancer Center2011-05-19
Hepatocellular Carcinoma (HCC) Transarterial Chemoembolisation (TACE) +Axitinib (NCT01352728)Chinese University of Hong Kong2011-05-18
BATTLE-FL: Front-Line Biomarker-Integrated Treatment Study in Non Small Cell Lung Cancer (NCT01263782)M.D. Anderson Cancer Center2011-05-17
Ofatumumab and Bendamustine Followed by Maintenance Ofatumumab for Rituximab Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (B-NHL) (NCT01294579)Novartis Pharmaceuticals2011-05-17
Efficacy Study of Pharmacokinetic(PK)/Pharmacodynamic(PD) Relationship of Monotherapy MORAb-004 in Metastatic Melanoma (NCT01335009)Eisai Inc.2011-05-16
Redirected Auto T Cells for Advanced Myeloma (NCT01352286)GlaxoSmithKline2011-05-13
Safety Study of Replagal® Therapy in Children With Fabry Disease (NCT01363492)Shire2011-05-12
SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma (NCT01362790)National Cancer Institute (NCI)2011-05-11
Reliability, Safety and Usability of the Transplantation Sensor System Combined With Myfortic® in Adult Kidney Transplant Patients (NCT01320358)Novartis Pharmaceuticals2011-05-10
Combination Immunotherapy and Autologous Stem Cell Transplantation for Myeloma (NCT01245673)University of Pennsylvania2011-05-10
Forced-dose Titration of SPD489 in Adults With Binge Eating Disorder (NCT01291173)Shire2011-05-10
Pilot Study of Hyperthermic Peritoneal Perfusion (HIPEC) for Adolescent and Young Adults With Desmoplastic Small Round Cell Tumor (NCT01277744)M.D. Anderson Cancer Center2011-05-09
HPA Axis Study in Japanese Adults (NCT01407510)Bayer2011-05-09
BAY94-8862 Dose Finding Trial in Subjects With Chronic Heart Failure and Mild (Part A) or Moderate (Part B) Chronic Kidney Disease (NCT01345656)Bayer2011-05-09
Infusional Carfilzomib in Patients With Relapsed or Refractory Multiple Myeloma (NCT01351623)Memorial Sloan Kettering Cancer Center2011-05-09
A Study to Test if Enzalutamide is Effective and Safe in Prostate Cancer Patients Who Have Never Had Hormone Therapy (NCT01302041)Astellas Pharma Inc2011-05-06
Bacterial Properties With LoFric® Catheters During Clean Intermittent Catheterization (NCT01305681)Nationwide Children's Hospital2011-05-06
Radiochemotherapy With and Without Dose Escalation in Patients Presenting Locally Advanced or Inoperable Carcinoma of the Oesophagus (NCT01348217)Centre Georges Francois Leclerc2011-05-06
Bevacizumab, Capecitabine, and Oxaliplatin in Treating Advanced Small Intestinal or Ampulla of Vater Adenocarcinoma (NCT01208103)M.D. Anderson Cancer Center2011-05-06
Bendamustine, Wkly Bortezomib, Lenalidomide and Dexamethasone for Multiple Myeloma (NCT01484626)Loyola University2011-05-05
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen (NCT01314118)Janssen Biotech, Inc.2011-05-04
Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Sebelipase Alfa in Children With Growth Failure Due to Lysosomal Acid Lipase Deficiency (NCT01371825)Alexion Pharmaceuticals, Inc.2011-05-04
Study to Evaluate the Effect of GWP42003 on Liver Fat Levels in Participants With Fatty Liver Disease (NCT01284634)GW Research Ltd2011-05-03
Dose Response of 28 Days of Dosing of GSK962040 in Type I and II Diabetic Male and Female Subjects With Gastroparesis (NCT01262898)GlaxoSmithKline2011-05-03
Colon Staining Efficacy of Single Oral Doses of Methylene Blue MMX (NCT03287219)Cosmo Technologies Ltd2011-05-02
Study of Carfilzomib for Multiple Myeloma Patients Who Are Relapsed/Refractory to Bortezomib-containing Treatments (NCT01365559)Oncotherapeutics2011-05-02
Study to Determine the Maximum Tolerated Dose of the PARP Inhibitor CEP-9722 in Participants With Solid Tumors (NCT01311713)Teva Branded Pharmaceutical Products R&D, Inc.2011-05-02
Effectiveness of a Multidisciplinary Care Management Program for High-risk Patients With Heart Failure (PROMIC) (NCT02436161)Basque Health Service2011-05-01
Safety and Efficacy Study of MBX-102 in Treatment of Hyperuricemia in Patients With Gout (NCT01336686)Gilead Sciences2011-05-01
A Clinical Trial in Patients With Breast Cancer Susceptibility Gene (BRCA) Defective Tumours (NCT01432145)University of Oxford2011-05-01
Efficacy and Safety Proof of Concept Study in Patients With Parkinson's Disease and End-of-dose Motor Fluctuations (NCT01766258)Orion Corporation, Orion Pharma2011-05-01
Fibrinogen Concentrate as Initial Treatment for Postpartum Haemorrhage: A Randomised Clinically Controlled Trial (NCT01359878)Copenhagen University Hospital at Herlev2011-05-01
Amorphous Calcium Carbonate (Acc) Versus Crystalline Calcium Carbonate (Ccc) Using Stable Calcium Isotopes In Postmenopausal Women (NCT01338142)Tel-Aviv Sourasky Medical Center2011-05-01
FOLFIRINOX in Patients With Inoperable Pancreatic Cancer (NCT01359007)University of Oklahoma2011-05-01
Autologous Bone Marrow Mononuclear Cell Transplantation in Treating Type 2 Diabetes Mellitus (NCT01677013)Peking University Aerospace Center Hospital2011-05-01
Cediranib Maleate With or Without Gefitinib in Treating Patients With Recurrent or Progressive Glioblastoma (NCT01310855)University College, London2011-05-01
Capecitabine and Pseudomonas Aeruginosa Combination in Metastatic Breast Cancer (MBC) (NCT01380808)Fudan University2011-05-01
A Double Blinded, Prospective, Randomized, Vehicle Controlled Multi-center Study of Photodynamic Therapy With Visonac® Cream in Patients With Acne Vulgaris (NCT01347879)Photocure2011-05-01
Effect of Carum Carvi on Thyroid Hormones and TSH Level (NCT01471288)Mashhad University of Medical Sciences2011-05-01
Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis (NCT01357980)Ipsen2011-05-01
Efficacy of FOLFOX+Bevacizumab in Combination With Irinotecan in the Treatment of Metastatic Colorectal Cancer (NCT01321957)Martin-Luther-Universität Halle-Wittenberg2011-05-01
Trastuzumab Administered Concurrently or Sequentially to Anthracycline-containing Adjuvant Regimen for Breast Cancer (NCT01413828)Peking Union Medical College Hospital2011-05-01
A Study of Danoprevir/Ritonavir and Copegus With RO5024048 and/or Pegasys in Patients With Chronic Hepatitis C (NCT01331850)Hoffmann-La Roche2011-05-01
Safety and Adherence of a Non-medicated Intravaginal Ring (IVR) (NCT01268332)Population Council2011-05-01
Consumption of Chocolate in Pregnant Women. (NCT01431443)Laval University2011-05-01
Low-Carbohydrate Diet Intervention on Body Weight (NCT01358890)Chinese Academy of Sciences2011-05-01
Study of Whole-brain Irradiation With Chloroquine for Brain Metastases (NCT01894633)Instituto Nacional de Cancerologia de Mexico2011-05-01
A Rollover Study for Patients Who Participated in Other Romidepsin Protocols (NCT01353664)Celgene2011-05-01
N-Acetyl-Cysteine (NAC) in Early Phase Schizophrenia Spectrum Psychosis (NCT01354132)Beth Israel Deaconess Medical Center2011-05-01
Safety and Efficacy Study of a BTK Inhibitor in Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma (NCT01325701)Pharmacyclics LLC.2011-05-01
Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia (NCT01361464)National Cancer Institute (NCI)2011-05-01
Paclitaxel-Carboplatin Alone or With M2ES for Non-Small-Cell Lung Cancer (NCT01527864)Protgen Ltd2011-05-01
Evaluation of the Effects of Chinese Medical Treatment on Leucopenia After Chemotherapy in Breast Cancer Patients (NCT01359501)China Medical University Hospital2011-05-01
Study of TG-C in Patients With Grade 3 Degenerative Joint Disease of the Knee (NCT01221441)Kolon TissueGene, Inc.2011-05-01
Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma (NCT01189253)European Organisation for Research and Treatment of Cancer - EORTC2011-05-01
Open-label Study to Assess Immunogenicity and Safety of a Vaccine Enhancement Patch When Administered With 2 Doses of H5N1 Vaccine (NCT01353534)Intercell USA, Inc.2011-05-01
← Previous Next →

Track Phase 2 automatically

Every clearance here is in the API, with alerts when new ones post.